Regulatory & Policy Updates

SHERIDAN, WYOMING - April 12, 2026 - The U.S. Senate passed legislation reauthorizing the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which had lapsed on September 30, 2025, cutting off competitive grant access for early-stage medtech companies. AdvaMed, the Medtech Association, publicly supported the Senate vote and called on the House of Representatives to act swiftly on passage. The programs channel competitive grants through 11 federal agencies - including the National Institutes of Health, the National Science Foundation, and the Department of Defense - directly to small medtech businesses at the most capital-constrained stages of product development. Restoring authorization removes a period of funding uncertainty that had stalled R&D planning across hundreds of early-stage medical device companies.

SHERIDAN, WYOMING - April 12, 2026 - Early-stage medtech companies that lost access to federal competitive grant funding when SBIR and STTR program authorization lapsed on April 12, 2026, now face a clearer path to restored capital after both chambers of Congress advanced reauthorization legislation. The Senate passed the measure first, followed by House passage of S. 3971, the Small Business Innovation and Economic Security Act, on April 12, 2026, bringing the programs within reach of full restoration pending presidential signature.

SHERIDAN, WYOMING - April 09, 2026 - Medtech supply chains across North America depend on the continued operation of the United States-Mexico-Canada Agreement, and a formal renewal keeps tariff predictability intact for the more than 650 medtech and health tech companies that AdvaMed represents - the majority of them small businesses.

Why USMCA matters to the medtech sector

The U.S. medtech industry spans manufacturing, research and development, and global healthcare delivery. Cross-border supply chains between the United States, Mexico, and Canada underpin both domestic production and the export leadership that U.S. medtech companies hold internationally. Without a stable trilateral trade framework, manufacturers face uncertainty in sourcing components, managing regulatory timelines, and forecasting capital investments.

SHERIDAN, WYOMING - April 09, 2026 - Product manufacturers and technology vendors selling into the European Union face a shifting compliance landscape as the European Commission advances its forthcoming European Product Act, prompting ETSI - the European Telecommunications Standards Institute - to publish a formal statement on the role of European standardisation in shaping that legislation.

What the European Product Act means for standards

The European Product Act is expected to consolidate and modernise the EU's product legislation framework, placing harmonised standards at the centre of conformity assessment. ETSI's statement positions European standardisation bodies as essential partners in the regulatory process, arguing that technically rigorous, consensus-based standards are the most reliable mechanism for translating legislative requirements into actionable product specifications.

SHERIDAN, WYOMING - April 09, 2026 - LNG market participants operating under EU jurisdiction now face revised data reporting requirements as the Agency for the Cooperation of Energy Regulators (ACER) updates its guidance on LNG market data submission and launches a dedicated Expert Group to refine price assessment methodology.

Updated LNG reporting guidance under REMIT

ACER's revised guidance directly addresses how market participants must submit data used to generate the agency's daily LNG price assessment and daily LNG benchmark. Both instruments are intended to provide reliable reference points that reflect actual trading conditions in the EU wholesale gas market, reducing the scope for pricing opacity that regulators have flagged as a systemic risk.

WASHINGTON, 4 March 2026: AdvaMed said the U.S. Senate has approved legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, and the association called on the House of Representatives to move quickly on passage. The medtech trade group said the vote matters because authorization for the two programs lapsed on 30 September 2025, leaving early-stage medical technology companies without the certainty they need as they pursue product research and development.

SHERIDAN, WYOMING - April 05, 2026 - Network vendors, radio access technology teams, and standards-track engineers now have a concrete architectural reference for building sensing capabilities directly into 6G systems, as ETSI's Industry Specification Group on Integrated Sensing and Communications has released GR ISC 003-a report that defines the structural foundations required to merge RF sensing with cellular communications at the system and RAN levels.

SHERIDAN, WYOMING - April 03, 2026 - Perimeter Medical Imaging AI has secured FDA premarket approval (PMA) for Claire, making it the first AI-enabled imaging device cleared in the United States for intraoperative breast cancer margin assessment during lumpectomy procedures. Claire, previously marketed as the Perimeter OCT B-Series with ImgAssist AI 2.0, holds FDA Breakthrough Device designation and targets an estimated 300,000 annual U.S. breast-conserving surgeries where residual disease forces re-operations in roughly one in five cases. The approval positions Perimeter to launch a nationwide commercial rollout in the weeks following clearance, converting a clinical trial asset into a revenue-generating platform with expansion potential across additional cancer indications.

SHERIDAN, WYOMING - April 03, 2026 - Gas network users across the Danish entry-exit zone face unverified cost exposure through non-transmission tariffs covering the upstream Baltic Pipe, as the EU Agency for the Cooperation of Energy Regulators (ACER) has determined that insufficient data prevents full compliance assessment of Energinet's proposed reference price methodology under EU rules.